vs

Side-by-side financial comparison of CHEGG, INC (CHGG) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $72.7M, roughly 1.1× CHEGG, INC). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -49.4%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -35.4%).

Chegg, Inc., is an American educational technology company based in Santa Clara, California. It provides homework help, digital and physical textbook rentals, textbooks, online tutoring, and other student services, powered by artificial intelligence. The company has 6.6 million subscribers. Chegg has been widely criticized for facilitating cheating and academic dishonesty among students.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CHGG vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.1× larger
PRCT
$83.1M
$72.7M
CHGG
Growing faster (revenue YoY)
PRCT
PRCT
+69.6% gap
PRCT
20.2%
-49.4%
CHGG
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-35.4%
CHGG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CHGG
CHGG
PRCT
PRCT
Revenue
$72.7M
$83.1M
Net Profit
$-31.6M
Gross Margin
57.3%
64.9%
Operating Margin
-47.2%
-4.1%
Net Margin
-38.1%
Revenue YoY
-49.4%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.30
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHGG
CHGG
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$72.7M
$76.4M
Q3 25
$77.7M
$83.3M
Q2 25
$105.1M
$79.2M
Q1 25
$121.4M
$69.2M
Q4 24
$143.5M
$68.2M
Q3 24
$136.6M
$58.4M
Q2 24
$163.1M
$53.4M
Net Profit
CHGG
CHGG
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-17.5M
$-21.4M
Q2 25
$-35.7M
$-19.6M
Q1 25
$-17.5M
$-24.7M
Q4 24
$-18.9M
Q3 24
$-212.6M
$-21.0M
Q2 24
$-616.9M
$-25.6M
Gross Margin
CHGG
CHGG
PRCT
PRCT
Q1 26
64.9%
Q4 25
57.3%
60.6%
Q3 25
59.2%
64.8%
Q2 25
66.3%
65.4%
Q1 25
55.5%
63.9%
Q4 24
68.2%
64.0%
Q3 24
68.2%
63.2%
Q2 24
72.2%
59.0%
Operating Margin
CHGG
CHGG
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-47.2%
-40.6%
Q3 25
-22.0%
-27.8%
Q2 25
-34.7%
-28.0%
Q1 25
-23.9%
-39.7%
Q4 24
-19.0%
-28.9%
Q3 24
-162.7%
-38.4%
Q2 24
-297.3%
-50.3%
Net Margin
CHGG
CHGG
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-22.5%
-25.7%
Q2 25
-33.9%
-24.7%
Q1 25
-14.4%
-35.8%
Q4 24
-27.6%
Q3 24
-155.7%
-35.9%
Q2 24
-378.1%
-48.0%
EPS (diluted)
CHGG
CHGG
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.30
$-0.54
Q3 25
$-0.16
$-0.38
Q2 25
$-0.33
$-0.35
Q1 25
$-0.17
$-0.45
Q4 24
$-0.03
$-0.34
Q3 24
$-2.05
$-0.40
Q2 24
$-6.01
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHGG
CHGG
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$72.8M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$119.6M
$347.7M
Total Assets
$278.0M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHGG
CHGG
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$72.8M
$286.5M
Q3 25
$96.4M
$294.3M
Q2 25
$85.6M
$302.7M
Q1 25
$88.3M
$316.2M
Q4 24
$315.7M
$333.7M
Q3 24
$361.1M
$196.8M
Q2 24
$345.5M
$214.1M
Total Debt
CHGG
CHGG
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CHGG
CHGG
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$119.6M
$365.9M
Q3 25
$146.1M
$380.3M
Q2 25
$157.9M
$385.8M
Q1 25
$185.7M
$389.2M
Q4 24
$193.0M
$402.2M
Q3 24
$185.0M
$241.2M
Q2 24
$365.5M
$251.8M
Total Assets
CHGG
CHGG
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$278.0M
$508.1M
Q3 25
$378.3M
$511.5M
Q2 25
$404.5M
$513.1M
Q1 25
$438.8M
$519.4M
Q4 24
$869.0M
$534.0M
Q3 24
$1.0B
$374.1M
Q2 24
$1.1B
$374.4M
Debt / Equity
CHGG
CHGG
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHGG
CHGG
PRCT
PRCT
Operating Cash FlowLast quarter
$-9.0M
Free Cash FlowOCF − Capex
$-15.5M
FCF MarginFCF / Revenue
-21.3%
Capex IntensityCapex / Revenue
8.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHGG
CHGG
PRCT
PRCT
Q1 26
Q4 25
$-9.0M
$-10.3M
Q3 25
$4.8M
$-6.6M
Q2 25
$-4.8M
$-15.0M
Q1 25
$24.5M
$-17.0M
Q4 24
$18.1M
$-32.4M
Q3 24
$39.5M
$-18.8M
Q2 24
$14.2M
$-15.7M
Free Cash Flow
CHGG
CHGG
PRCT
PRCT
Q1 26
Q4 25
$-15.5M
$-12.2M
Q3 25
$-943.0K
$-9.5M
Q2 25
$-12.1M
$-17.8M
Q1 25
$15.9M
$-18.8M
Q4 24
$4.8M
$-33.6M
Q3 24
$23.7M
$-19.0M
Q2 24
$-3.6M
$-16.8M
FCF Margin
CHGG
CHGG
PRCT
PRCT
Q1 26
Q4 25
-21.3%
-15.9%
Q3 25
-1.2%
-11.4%
Q2 25
-11.5%
-22.5%
Q1 25
13.1%
-27.2%
Q4 24
3.4%
-49.2%
Q3 24
17.3%
-32.6%
Q2 24
-2.2%
-31.4%
Capex Intensity
CHGG
CHGG
PRCT
PRCT
Q1 26
Q4 25
8.9%
2.4%
Q3 25
7.4%
3.4%
Q2 25
6.9%
3.5%
Q1 25
7.1%
2.7%
Q4 24
9.3%
1.7%
Q3 24
11.6%
0.4%
Q2 24
10.9%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHGG
CHGG

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons